• T-Cell Receptor Gene Rearrangement, Flow Cytometry, Blood
  • Lead poisoning
  • Ankylosing spondylitis
  • Familial adenomatous polyposis
  • BDX-XL2, EarlyCDT®-Lung, Blood Test for Early Detection of Lung Cancer
  • Adenovirus DNA, Real-Time PCR, Quantitative
  • Fluoxetine, Urine
  • Cholelithiasis (gallstones)
  • MSH2 Gene Mutation Analysis (Known Mutations, Duplication/Deletion/Sequencing)
  • Carcinoembryonic Antigen (CEA), Serum
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /MLH1 Hypermethylation (Promoter Methylation) Analysis, Tissue
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

MLH1 Hypermethylation (Promoter Methylation) Analysis, Tissue
Medical Test

References
Access to MLH1 Hypermethylation (Promoter Methylation) Analysis, Tissue is restricted.